Breaking News
Get 40% Off 0
🚀 Our AI Picked 6 Stocks that Jumped +25% in Q1. Which Picks Will Soar in Q2? Unlock full list
Close

Bristol-Myers Squibb Company (BMY)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Bristol-Myers Squibb's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
48.28 -0.84    -1.71%
06:00:00 - Closed. Currency in USD ( Disclaimer )
After Hours
48.38
+0.10
+0.21%
9:59:40 - Real-time Data
  • Volume: 11,868,148
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 48.26 - 49.08
Type:  Equity
Market:  United States
Bristol-Myers Squibb 48.28 -0.84 -1.71%

BMY Financial Summary

 
A brief financial summary of Bristol-Myers Squibb Company as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Bristol-Myers Squibb Company reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 321 million compared to USD 405 million a year ago. Revenue was USD 10,966 million compared to USD 11,218 million a year ago. Net income was USD 1,928 million compared to USD 1,606 million a year ago. Basic earnings per share from continuing operations was USD 0.94 compared to USD 0.75 a year ago. Diluted earnings per share from continuing operations was USD 0.93 compared to USD 0.75 a year ago.For the nine months, sales was USD 919 million compared to USD 1,147 million a year ago. Revenue was USD 33,529 million compared to USD 34,753 million a year ago. Net income was USD 6,263 million compared to USD 4,305 million a year ago. Basic earnings per share from continuing operations was USD 3.01 compared to USD 2.01 a year ago. Diluted earnings per share from continuing operations was USD 2.99 compared to USD 2 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

BMY Income Statement

Gross margin TTM 76.63%
Operating margin TTM 19.22%
Net Profit margin TTM 17.83%
Return on Investment TTM 10.05%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 11477 10966 11226 11337
Gross Profit 8770 8476 8417 8825
Operating Income 1952 2104 1994 2506
Net Income 1762 1928 2073 2262

BMY Balance Sheet

Quick Ratio MRQ 1.06
Current Ratio MRQ 1.43
LT Debt to Equity MRQ 124.74%
Total Debt to Equity MRQ 141.08%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 95159 91263 93489 94281
Total Liabilities 65674 62201 61459 62395
Total Equity 29485 29062 32030 31886

BMY Cash Flow Statement

Cash Flow/Share TTM 6.81
Revenue/Share TTM 22.12
Operating Cash Flow  19.10%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 4252 4751 1887 2970
Cash From Investing Activities -1346 -410 -329 -210
Cash From Financing Activities 967 -5160 -2173 -3050
Net Change in Cash 3951 -857 -623 -277
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BMY Comments

Write your thoughts about Bristol-Myers Squibb Company
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email